Skip to search.
 TSX Up 1.03% TSX Ventures  0.00%
Streaming
Ticker Tape: On

More On PBMD

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

Financials

Prima Biomed Ltd. (PBMD)

-NasdaqGM

2.40 May 21, 10:23AM EDT

Add to Portfolio
Prev Close:2.40
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:N/A
Beta:2.692
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:1.70 - 7.49
Volume:0
Avg Vol (3m):2,984
Market Cap:85.28M
P/E (ttm):N/A
EPS (ttm):-0.54
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
PBMD 0.00%85.28M
RHHBYN.MXUp 0.14%2.66T
SHP.LDown 0.84%11.68B
SUNPHARMA.NSUp 2.88%1.04T
GILD.MXUp 2.12%1.06T

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):54.81
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Prima BioMed Ltd, a biotechnology company, engages in the research and commercialization of licensed medical biotechnology products in Australia. It develops oncology therapies in the field of immunotherapy. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback